Predictors of immunotherapy induced immune-related adverse events
Conclusion: The prevalence of IRAE in our sample is similar to the reported in literature. Pts with higher BMI are more likely to experience IRAE. One potential explanation is pharmacokinetic changes induced by overweight.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Barata, M., Santos, G., Grumete, H., Lopes, M., Canario, D., Duarte, J. Tags: Lung cancer Source Type: research
More News: Autoimmune Disease | Cancer | Cancer & Oncology | Corticosteroid Therapy | Gastroenterology | Immunotherapy | Lung Cancer | Obesity | Respiratory Medicine | Skin | Statistics | Thyroid | Thyroid Cancer | Toxicology | Urology & Nephrology